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BACKGROUND: Several guidelines recommend initiat-
ing colorectal cancer screening at age 40 for individuals
with affected first-degree relatives, yet little evidence
exists describing how often these individuals receive
screening procedures.
OBJECTIVES: To determine the proportion of individ-
uals in whom early initiation of colorectal cancer
screening might be indicated and whether screening
disparities exist.
DESIGN: Population-based Supplemental Cancer Con-
trol Module to the 2000 National Health Interview
Survey.
PARTICIPANTS: Respondents, 5,564, aged 40 to
49 years were included within the analysis.
MEASUREMENTS: Patient self-report of sigmoidosco-
py, colonoscopy, or fecal occult blood test.
RESULTS: Overall, 279 respondents (5.4%: 95% C.I.,
4.7, 6.2) reported having a first-degree relative affected
with colorectal cancer. For individuals with a positive
family history, 67 whites (27.9%: 95% C.I., 21.1, 34.5)
and 3 African American (9.3%: 95% C.I., 1.7, 37.9) had
undergone an endoscopic procedure within the previ-
ous 10 years (P-value=.03). After adjusting for age,
family history, gender, educational level, insurance
status, and usual source of care, whites were more
likely to be current with early initiation endoscopic
screening recommendations than African Americans
(OR=1.38: 95% C.I., 1.01, 1.87). Having an affected
first-degree relative with colorectal cancer appeared to
have a stronger impact on endoscopic screening for
whites (OR=3.21: 95% C.I., 2.31, 4.46) than for African
Americans (OR=1.05: 95% C.I., 0.15, 7.21).
CONCLUSIONS: White participants with a family histo-
ry are more likely to have endoscopic procedures
beginning before age 50 than African Americans.
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BACKGROUND
Randomized controlled trials and observational studies have
demonstrated that colorectal cancer screening with fecal
occult blood testing (FOBT) and/or endoscopy reduces cancer
mortality and incidence.
1–6 Indeed, the use of these screening
procedures is believed to have contributed to the decline seen
in colorectal cancer (CRC) mortality over the last few decades.
7
In the general population, the incidence of CRC begins to
increase steeply with age with over 90% of cases occurring
after 50 years of age.
8 As such, most organizations recommend
initiating CRC screening beginning at age 50 for average risk
people.
9–11
For individuals who are at an increased risk of developing
CRC because of their family history, the most effective
screening strategy remains to be fully elucidated.
12 Several
studies have confirmed that having an affected relative with
CRC can double to quadruple one’s lifetime risk of developing
colorectal cancer.
13 Incident cancer cases in individuals with
affected first-degree relatives present, on average, 10 years
earlier than in individuals with no affected relatives.
14 This
“age shift” in CRC incidence rates underlies much of the
rationale for initiating screening at age 40 in individuals with
affected first-degree relatives.
9
Although overall mortality rates for CRC have been on the
decline, the rate of this decline has been greater for whites
than African Americans.
7 African Americans have a 19%
higher incidence rate of CRC and a 39% higher mortality
rate.
15 Part of the reason for this mortality difference results
from African Americans being more likely to present with
advanced stages of CRC.
16,17 Another factor that may contrib-
ute to higher CRC mortality rates in African Americans might
be inequities in screening rates. Although screening inequities
have been described for average risk individuals, they have
typically been modest and more often related to socioeconomic
status than race.
18–23 Nevertheless, even modest differences in
screening rates could be related to survival differences if the
individuals with the greatest risk for developing CRC are less
likely to undergo screening. The purpose of this study was to
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121determine the prevalence of individuals who might be candi-
dates for early initiation of CRC screening based on their
family history and to determine whether screening rates differ
between African Americans and white individuals with affected
first-degree relatives.
DESIGN, PARTICIPANTS, MEASUREMENTS
The data source for this study was the Cancer Control Module
of the 2000 National Health Interview Survey (NHIS). The NHIS
is an in-person health interview conducted by the U.S. Census
Bureau for the National Center for Health Statistics.
24 The
NHIS uses a multistage probability sample design to represent
current health information for the civilian, noninstitutional-
ized, household population of the United States. For the year
2000 survey, the overall sample adult response rate was
72.1%.
25 In 2000, a supplement to the core NHIS was the
Cancer Control Module.
24 This module consisted of seven
sections covering health behavior, family cancer history, and
cancer screening. For the 2000 Cancer Control Module,
32,374 persons, 18 years or older, were interviewed. A total of
5,564 respondents were eligible for our analysis (Fig. 1).
All adults over the age of 40 were asked about CRC
screening procedures and the date of the most recent exami-
nation. A respondent was considered to have undergone CRC
screening if they reported ever having had a colonoscopy,
sigmoidoscopy, or home-based fecal occult blood testing
(FOBT). Because office-based fecal occult testing is not con-
sidered an appropriate CRC screening strategy, we did not
include this within our analysis.
9 The 2000 Cancer Control
Module did not inquire about barium enema testing, and as
such, this variable could not be included within our analysis.
We considered respondents to be current with FOBT if they
reported having at least one test within the past year.
Sigmoidoscopy and colonoscopy were collapsed into a single
endoscopy variable. Respondents were considered to be cur-
rent with endoscopic screening if they reported having at least
one of these procedures within the previous 10 years. Because
sigmoidoscopy screening is recommended to occur at 5-year
intervals, we performed a secondary analysis in which we
defined being current with endoscopic screening as reporting
at least one procedure during the previous 5 years. Models
were then constructed using both definitions (10 and 5 years)
for endoscopic screening. The primary analysis included the
10-year screening definition. When data are presented relating
to the 5-year interval definition, this is indicated specifically
within the text.
To determine if an individual might be a candidate for early
initiation of cancer screening, we used guidelines available in
2000.
26–28 At this time, the American Cancer Society was
recommended initiating CRC screening at age 40 in individ-
uals with either a first-degree relative affected with CRC before
age 60 years while the American Gastroenterology Association
(AGA) suggested early initiation of CRC surveillance for any
individual with an affected first-degree relative.
27 For the
purpose of this analysis, we used the conservative AGA
recommendations and considered any individuals with an
affected first-degree relative, regardless of age, as a candidate
for early initiation of CRC screening.
Respondents who reported undergoing endoscopy or FOBT
were asked to give the reason for undergoing the procedure.
Responses were categorized as: (1) part of a routine physical
exam/screening test, (2) because of a specific problem, (3)
follow-up test of an earlier test or screening exam, (4) family
history, or (5) other. Respondents also rated their own
perceived likelihood of developing cancer by responding to the
question, “Would you say your risk of getting cancer in the
future is low, medium, or high.” For the purpose of our
analysis, we dichotomized this response into “low likelihood”
and “medium or high likelihood.”
We used self-reported demographic information to construct
our independent covariates. Individuals who reported their
typical source of health care as a clinic, health center, doctor’s
office, health maintenance organization, or a hospital outpa-
tient department were categorized as having a usual source of
care. Respondents who indicated that they had no usual
source of care or obtained their typical health care through
an emergency room were categorized as having no usual
source of care. We grouped self-reported educational levels
into four categories: less than high school, graduated high
school, some college, and graduated college with or without
professional or graduate school. We categorized respondents
into those with insurance coverage, defined as individuals with
private insurance, military insurance, other governmental
insurance, Medicare or Medicaid, and those reporting no
insurance coverage whatsoever.
Screening rates were stratified by family history and race.
We only included respondents whose self-reported race was
either “white” or “black.” We did not include respondents
reporting other races within the analysis, as these groups were
small. We used χ
2 tests to compare screening rates between
groups.
To determine the impact of race on early initiation of CRC
screening in increased risk individuals, we constructed a
separate logistic multivariate model for each CRC screening
outcome (endoscopy within the preceding 10 years and FOBT
within the past year). These models were adjusted for potential
confounders to CRC screening including age, race, family
history, gender, education, insurance status, and having a
usual source of care.
24 To further determine the impact of a
positive family history for white and African-American respon-
dents, we created two additional logistic multivariate models Figure 1. Study population CRC = colorectal cancer.
122 Murff et al.: Family History and Colorectal Cancer Screening JGIMwhich were stratified by race. All data analyses were weighted
to reflect national population estimates. To account for the
NHIS multistage probability sample design, standard errors
were adjusted using SAS-callable SUDAAN software, version 9
(Research Triangle Institute, Research Triangle Park, NC).
RESULTS
Overall, 279 respondents (5.4%: 95% C.I., 4.7, 6.2) reported
having one or more first-degree relatives affected with CRC.
African Americans and whites, aged 40 to 49 years, had
similar rates of positive family histories for CRC (3.9%: 95%
C.I., 2.5, 6.1 vs 5.6%: 95% C.I., 5.0, 6.4, P-value=.09). Among
individuals with a positive family history, 67 (27.9%: 95% C.I.,
22.1, 34.5) white respondents had undergone an endoscopic
procedure within the previous 10 years compared to 3 (9.3%:
95% C.I., 1.7, 37.9) African-American respondents (P=.03).
Among individuals without affected first-degree relatives,
whites were more likely to have undergone an endoscopic
procedure when compared to African Americans (10.5%: 95%
C.I., 9.54, 11.6 vs 7.6%: 95% C.I., 5.8, 9.9, P-value=.01). Rates
of FOBT screening for individuals with and without a family
history of CRC are presented in Table 1.
Table 1. Participation in Colorectal Cancer Screening Procedures in individuals Ages 40 to 49 Years Categorized by Family History
Endoscopy within past 10 years Fecal occult blood testing within past 1 year*
White African American P White African American P
Positive family history Percent, (95% CI) 27.9% (22.1, 34.5) 9.3% (1.7, 37.9) .03 10.8% (7.0, 16.3) 3.5% (0.74, 15.2) .08
N 67/248 3/31 24/248 2/31
No family history Percent, (95% CI) 10.5% (9.54, 11.6) 7.6% (5.8, 9.9) .01 6.0% (5.2, 6.9) 4.6% (3.3, 6.4) .13
N 462/4418 69/867 253/4387 43/863
*Denominator excludes 35 individuals (0.6%) with missing information on fecal occult blood testing.
Table 2. Association of Colorectal Cancer Family History with Early-Initiation of Colorectal Cancer Screening interventions in Individuals Ages
40 to 49 Years*
Characteristic Endoscopy within past 10 years
Full model N=5564 OR
† (95% CI) White N=4,666 OR (95% CI) African American N=898 OR (95% CI)
Race White 1.38 (1.01, 1.87)
African American 1.00
Family history Positive family
history
3.05 (2.21, 4.20) 3.21 (2.31, 4.46) 1.05 (0.15, 7.21)
No family history 1.00 1.00 1.00
Gender Female 0.81 (0.66, 0.98) 0.84 (0.69, 1.03) 0.55 (0.31, 0.95)
Male 1.00 1.00 1.00
Education level College or prof grad 1.53 (1.04, 2.26) 1.62 (1.06, 2.48) 0.98 (0.27, 3.55)
Some college 1.42 (0.96, 2.10) 1.45 (0.93, 2.24) 1.55 (0.63, 3.83)
High school grad 1.09 (0.74, 1.60) 1.17 (0.76, 1.81) 0.61 (0.22, 1.65)
<High school 1.00 1.00 1.00
Insurance status None 0.81 (0.51, 1.27) 0.80 (0.48, 1.32) 0.96 (0.37, 2.47)
Any insurance 1.00 1.00 1.00
Usual source of care Yes 2.85 (1.88, 4.31) 2.70 (1.75, 4.17) 5.50 (1.37, 22.12)
No 1.00 1.00 1.00
FOBT‡ within past 1 year
Race White 1.23 (0.83, 1.83)
African American 1.00
Family history Positive family
history
1.62 (1.00, 2.64) 1.71 (1.03, 2.84) 0.76 (0.14, 3.99)
No family history 1.00 1.00 1.00
Gender Female 1.23 (0.94, 1.60) 1.21 (0.92, 1.60) 1.37 (0.61, 3.06)
Male 1.00 1.00 1.00
Education level College or prof grad 2.88 (1.55, 5.36) 2.50 (1.28, 4.88) 7.47 (1.93, 28.92)
Some college 1.90 (1.01, 3.58) 1.68 (0.84, 3.35) 4.20 (1.04, 16.92)
High school grad 1.84 (0.97, 3.48) 1.65 (0.83, 3.28) 3.09 (0.75, 12.70)
<High school 1.00 1.00 1.00
Insurance status None 0.91 (0.52, 1.60) 0.84 (0.44, 1.61) 1.25 (0.35, 4.52)
Any insurance 1.00 1.00 1.00
Usual source of care Yes 4.48 (2.32, 8.65) 6.90 (2.97, 16.03) 1.01 (0.29, 3.52)
No 1.00 1.00 1.00
*All models adjusted for age (continuous), family history, gender, educational level, insurance status, income, and having a usual source of care.
†OR = odds ratio.
‡Fecal occult blood testing.
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diagnostic and screening reasons, endoscopy procedures were
further categorized into screening procedures; defined as those
where the respondent reported that the procedure had been
performed as “part of a routine physical exam/screening test”
or “family history” and diagnostic procedures, defined as
“because of a specific problem,”“ follow-up test of an earlier
test/screening test,” or “other.” Overall, 49 endoscopies
(70.5%: 95% C.I., 58.0, 80.5) performed in individuals with
affected first-degree relatives were performed for screening
purposes. White respondents with a positive family history
reported 46 endoscopies (69.5%: 95% C.I., 56.9, 79.8) per-
formed for screening purposes while African American respon-
dents reported 3 endoscopic procedures (100%) performed for
screening purposes (P=.26). In white respondents with positive
family histories for CRC, 26 (41.1%: 95% C.I., 26.4, 53.9)
reported family history as the reason for undergoing the
endoscopy procedure compared to no African-American
respondents (P=.25).
In the full model including all eligible subjects (n=5,564),
after adjusting for patient age, family history, gender, insur-
ance status, education, and having a usual source of care,
white respondents had an odds of 1.38 (95% C.I., 1.01, 1.87) of
having undergone an endoscopic procedure within the past
10 years compared to African-Americans (P=.04) (Table 2).
Individuals with a family history of CRC had an increased odds
of 3.05 (95% C.I., 2.21, 4.20) of being current with endoscopy
compared to individuals without family histories (P<.0001). In
the adjusted models stratified by race, white individuals with
an affected first degree relative with CRC had an odds of 3.21
(95% C.I., 2.31, 4.46) of being up-to-date with endoscopic
screening when compared to white individuals with no affected
relatives, while African-American respondents with a positive
family history had an odds of 1.05 (95% C.I., 0.15, 7.21) of
current with endoscopy compared to African Americans with
no affected relatives. Results of the analysis using FOBT as the
outcome are presented in Table 2. Family history was associ-
ated with an increased odds of being up to date with FOBT
testing in white individuals but not in African-American
individuals; however, in the full adjusted model, white individ-
uals were not statistically more likely to have undergone FOBT
than African Americans (OR=1.23: 95% C.I., 0.83, 1.83).
When defining current with endoscopic procedures as
having undergone at least one procedure within the past
5 years, having a positive family history was associated with
an adjusted odds of 3.16 (95% C.I., 2.25, 4.45) when compared
to an individual with no affected relatives for being current
with endoscopy within the full model (data not shown). Race
was not a significant predictor of endoscopy screening, with
whites having an adjusted odds of 1.20 (95% C.I., 0.86, 1.67)
of having undergone an endoscopic procedure within the
preceding 5 years when compared to African Americans. In
the models stratified by race, the adjusted odds ratio for being
having undergone an endoscopic procedure within the previ-
ous 5 years in individuals with a family history of CRC when
compared to individuals without a family history was 3.34
(95% C.I., 2.36, 4.74) and 1.20 (95% C.I., 0.18, 8.26) in whites
and African Americans, respectively.
For respondents aged 40 to 49 years, self-perceived cancer
risk was compared in individuals with affected first-degree
relatives and those with no affected relatives (Fig. 2). In
individuals with positive family histories of CRC, 201 white
respondents (82.5%: 95% C.I., 76.9, 87.0) compared to 12
African-American respondents (36.5%: 95% C.I., 19.6, 57.6)
perceived themselves as having a medium or high likelihood of
developing cancer (P=.004). In individuals with no family
history of CRC, 1,924 (46.6%: 95% C.I., 44.9, 48.4) whites
and 276 (33.3%: 95% C.I., 29.4, 37.4) African Americans
perceived themselves as at medium or high likelihood of
developing cancer (P<.0001).
CONCLUSION
We found that approximately 1 in 20 white and African-
American individuals who were aged 40 to 49 were potential
Figure 2. Respondent’s with positive family histories for colorectal cancer self-perceived likelihood of developing cancer compared to
respondents with no family history. Numbers displayed within the bars are the sample size for each category
*P-value=.004
†P-value<.0001.
124 Murff et al.: Family History and Colorectal Cancer Screening JGIMcandidates for early initiation of CRC screening based on their
family history. Screening rates were variable with African-
American respondents being less likely to have undergone
CRC screening compared to whites. After adjusting for age,
gender, insurance, education, and having a usual provider, a
positive family history was an important predictor of being up
to date with a CRC screening procedure for whites but less so
for African Americans. Finally, substantially fewer African
Americans with positive family histories for CRC perceived
themselves to be at increased risk for developing cancer
compared to white respondents.
Although many studies have determined the rates of CRC
screening in average risk individuals, only a few studies exist
which have evaluated rates in individuals at increased risk. In
one survey of provider practice patterns, 85% of gastroenterol-
ogists and 72% of primary care providers noted that they chose
age 40 as the age to initiate screening for individuals with a
familyhistory ofCRC.
29Despitethesehighself-reportedratesof
screening, our study found rates that were much lower. This is
likely because of two factors. First, 15% of NHIS respondents
reported having no usual source for heath care, an important
factor in CRC screening.
22 Second, although providers may
follow appropriate screening recommendations when they have
identified an individual at increased risk, family history infor-
mation is collected in less than half of primary care visits
30, and
when obtained, the information is often of poor quality and not
useful for cancer risk assessment.
31 Thus, it is possible that
health care providers may not be identifying all individuals who
are at increased risk because of their family histories.
We are unable to determine in our study whether family
history information is less likely to be collected and acted upon
from African-American patients compared to white patients or
whether African-American patients are less likely to be moti-
vated to seek screening based on their family history. Provider-
specific factors, such as time constraints, competing patient
demands, or knowledge deficits regarding clinical genetics
could impact whether providers actively solicit family history
information; however, limited evidence exists on this topic.
Some studies have suggested that African-American women
are less likely to be informed of the increased breast cancer
risk associated with their family history; however, this finding
has not been consistent.
32,33 It is unknown if these differences
also exist for CRC.
Patient-specific factors additionally contribute to how family
history information affects medical care. It is clear that
different cultures have different views on what constitutes a
family unit and the appropriateness of sharing family history
information with nonfamily members.
34 In general, women
with a positive family history of breast cancer undergo
screening more frequently than women without a family
history
35; however, this relationship has not been as reliable
for African-American women.
36,37 How knowledge of one’s
family history impacts perceived cancer risk and subsequent
preventive behaviors is not entirely understood.
35,38,39 In our
study, no African Americans noted family history as the reason
for undergoing screening compared to 41% of white partici-
pants who described this as a factor. It is possible that African-
American participants did not indicate family history as a
reason for undergoing CRC screening because they may have
perceived the risk associated with a positive family history as
less important with regard to cancer risk when compared to
white participants. In our study, fewer African Americans with
affected relatives perceive themselves as at an increased risk
for cancer compared to whites, although these results should
be interpreted with caution as we did not exclude individuals
with family histories for other cancer, such as breast or
prostate, which may have a greater impact on perceived cancer
risk than CRC.
There are several limitations to our study; most notable is
that the NHIS Cancer Control Module only recorded informa-
tion pertaining to first-degree relatives. This strategy was
appropriate as previous evidence has indicated that self-
reported family history information for colorectal, breast, and
prostate cancer is highly accurate for first-degree relatives but
becomes less so for second- and third-degree relatives.
40 In
addition, the NHIS does not inquire about a family history of
adenomatous polyps. It is unclear how many individuals
classified as having no family history were being screened as
a result of affected second-degree relatives or a family history
of adenomatous polyps. A second limitation of our study is the
age of the data source. The most recent NHIS Cancer Control
Module was administered in 2000. Several cancer-screening
guidelines have recently changed, and we were only able to
determine screening in compliance with 1997 guidelines. We
also relied on patient self-report of CRC screening procedures
as opposed to actual medical records to determine procedure
rates. Several studies have suggested that patient self-report
may overestimate colorectal screening rates and underesti-
mate screening intervals.
41–43 Our regression coefficients may
also be biased by endogeneity, particularly if having a family
history of CRC impacts an individuals desire to obtain health
insurance or establish a usual source of care. Finally, although
the NHIS includes data on over 30,000 individuals, the
number of respondents, aged 40 to 49 with a positive family
history, represented a relatively small subset of this popula-
tion, and as such, our confidence intervals were large and our
power somewhat limited to detect a true difference.
In conclusion, 1 in 20 individuals, aged 40 to 49 years, are
candidates for early initiation of CRC screening. African-
American individuals undergo early initiation of CRC screen-
ing at lower rates when compared to whites, with family
history having little to no association with screening. Future
work will be needed to determine how cultural differences
impact risk perception and health-seeking behaviors in
individuals with positive family histories and if family history
of colorectal cancer may motivate individuals to undergo
screening. Answers to these questions will be necessary if
providers wish to gain maximal utility from family history
information.
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